 Andrew Libby
Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Perilipin-2 | 3 | 2019 | 40 | 1.180 |
Why?
| | Lipid Metabolism | 5 | 2025 | 529 | 1.160 |
Why?
| | Ovariectomy | 2 | 2025 | 166 | 0.990 |
Why?
| | Leptin | 2 | 2025 | 248 | 0.960 |
Why?
| | Adipocytes | 3 | 2025 | 223 | 0.950 |
Why?
| | Adipose Tissue, White | 3 | 2024 | 43 | 0.920 |
Why?
| | Non-alcoholic Fatty Liver Disease | 5 | 2022 | 265 | 0.920 |
Why?
| | Rats, Wistar | 1 | 2024 | 450 | 0.750 |
Why?
| | Hematopoietic Stem Cells | 2 | 2025 | 435 | 0.730 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 266 | 0.730 |
Why?
| | Insulin Resistance | 4 | 2025 | 1244 | 0.690 |
Why?
| | Estradiol | 1 | 2024 | 515 | 0.630 |
Why?
| | Triglycerides | 3 | 2025 | 520 | 0.600 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2020 | 117 | 0.590 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 209 | 0.580 |
Why?
| | Adipose Tissue, Brown | 2 | 2022 | 60 | 0.570 |
Why?
| | Lipoprotein Lipase | 2 | 2018 | 56 | 0.570 |
Why?
| | Carbohydrate Metabolism | 1 | 2018 | 59 | 0.540 |
Why?
| | Energy Metabolism | 1 | 2024 | 935 | 0.530 |
Why?
| | Adenosine Triphosphate | 1 | 2020 | 500 | 0.520 |
Why?
| | Gene Deletion | 1 | 2018 | 392 | 0.490 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2016 | 56 | 0.490 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 47 | 0.480 |
Why?
| | Liver | 3 | 2024 | 1899 | 0.460 |
Why?
| | Apolipoproteins | 1 | 2015 | 38 | 0.450 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 143 | 0.440 |
Why?
| | Temperature | 1 | 2018 | 633 | 0.440 |
Why?
| | Hypothalamus | 1 | 2015 | 163 | 0.420 |
Why?
| | Kidney | 3 | 2023 | 1497 | 0.300 |
Why?
| | Mice | 12 | 2025 | 18355 | 0.270 |
Why?
| | Animals | 15 | 2025 | 38101 | 0.250 |
Why?
| | Neurons | 1 | 2015 | 1652 | 0.240 |
Why?
| | Fatty Acid Synthase, Type I | 1 | 2025 | 11 | 0.220 |
Why?
| | Peroxisome Proliferator-Activated Receptors | 2 | 2022 | 17 | 0.210 |
Why?
| | Cholesterol | 3 | 2022 | 408 | 0.210 |
Why?
| | Mice, Inbred C57BL | 6 | 2025 | 5992 | 0.200 |
Why?
| | Hepatitis, Autoimmune | 1 | 2023 | 14 | 0.190 |
Why?
| | Diet, Western | 2 | 2022 | 88 | 0.190 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 242 | 0.190 |
Why?
| | Endogenous Retroviruses | 1 | 2023 | 37 | 0.180 |
Why?
| | Bile Acids and Salts | 2 | 2022 | 163 | 0.180 |
Why?
| | Fatty Liver | 2 | 2022 | 253 | 0.180 |
Why?
| | Ovary | 1 | 2024 | 234 | 0.180 |
Why?
| | Intra-Abdominal Fat | 1 | 2022 | 101 | 0.170 |
Why?
| | Liver X Receptors | 1 | 2020 | 29 | 0.160 |
Why?
| | Anions | 1 | 2020 | 29 | 0.160 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.160 |
Why?
| | Body Composition | 1 | 2024 | 693 | 0.150 |
Why?
| | Liver Diseases | 1 | 2023 | 305 | 0.150 |
Why?
| | Body Weight | 1 | 2024 | 972 | 0.150 |
Why?
| | Reperfusion Injury | 1 | 2022 | 292 | 0.150 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2025 | 883 | 0.150 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2019 | 10 | 0.140 |
Why?
| | Retroviridae | 2 | 2018 | 100 | 0.140 |
Why?
| | Microscopy, Fluorescence | 1 | 2020 | 408 | 0.140 |
Why?
| | Obesity | 4 | 2022 | 3118 | 0.140 |
Why?
| | Rats | 2 | 2024 | 5585 | 0.140 |
Why?
| | Thermogenesis | 1 | 2018 | 45 | 0.130 |
Why?
| | Lipogenesis | 1 | 2018 | 62 | 0.130 |
Why?
| | Muscle, Striated | 1 | 2018 | 12 | 0.130 |
Why?
| | Genetic Vectors | 2 | 2018 | 335 | 0.130 |
Why?
| | Hepatocytes | 1 | 2019 | 224 | 0.130 |
Why?
| | Transcriptome | 1 | 2024 | 1042 | 0.130 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 188 | 0.120 |
Why?
| | Metabolic Diseases | 1 | 2018 | 114 | 0.120 |
Why?
| | Lactation | 1 | 2018 | 193 | 0.120 |
Why?
| | Intracellular Membranes | 1 | 2016 | 77 | 0.120 |
Why?
| | Mice, Knockout | 3 | 2022 | 3130 | 0.120 |
Why?
| | Kidney Diseases | 1 | 2020 | 426 | 0.120 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 178 | 0.120 |
Why?
| | Dietary Fats | 1 | 2018 | 308 | 0.120 |
Why?
| | Agouti-Related Protein | 1 | 2015 | 3 | 0.110 |
Why?
| | Learning | 1 | 2020 | 444 | 0.110 |
Why?
| | Lipid Droplets | 1 | 2015 | 21 | 0.110 |
Why?
| | Genetic Therapy | 1 | 2018 | 316 | 0.110 |
Why?
| | Cell Line, Transformed | 1 | 2015 | 138 | 0.110 |
Why?
| | Inflammation | 2 | 2023 | 2884 | 0.110 |
Why?
| | Endoplasmic Reticulum | 1 | 2016 | 264 | 0.100 |
Why?
| | Biological Transport | 1 | 2015 | 424 | 0.100 |
Why?
| | Breast Feeding | 1 | 2018 | 447 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 1101 | 0.100 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2393 | 0.090 |
Why?
| | Glucose | 3 | 2022 | 1049 | 0.090 |
Why?
| | Homeostasis | 1 | 2015 | 644 | 0.080 |
Why?
| | Adipose Tissue | 3 | 2022 | 645 | 0.080 |
Why?
| | Insulin | 1 | 2022 | 2516 | 0.080 |
Why?
| | Gene Expression | 1 | 2015 | 1478 | 0.080 |
Why?
| | Female | 5 | 2025 | 79045 | 0.080 |
Why?
| | Diet | 1 | 2018 | 1278 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2601 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2602 | 0.070 |
Why?
| | Diet, High-Fat | 2 | 2019 | 266 | 0.060 |
Why?
| | Biomarkers | 1 | 2018 | 4302 | 0.060 |
Why?
| | Humans | 9 | 2025 | 145783 | 0.060 |
Why?
| | Cytokines | 2 | 2023 | 2069 | 0.050 |
Why?
| | Tamoxifen | 1 | 2025 | 193 | 0.050 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2023 | 39 | 0.050 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2025 | 196 | 0.050 |
Why?
| | Activating Transcription Factor 6 | 1 | 2023 | 19 | 0.050 |
Why?
| | eIF-2 Kinase | 1 | 2023 | 28 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Unfolded Protein Response | 1 | 2023 | 58 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 22 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2022 | 112 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 85 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 57 | 0.050 |
Why?
| | Mice, Obese | 1 | 2022 | 68 | 0.050 |
Why?
| | Subcutaneous Fat | 1 | 2022 | 79 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2023 | 118 | 0.040 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 65 | 0.040 |
Why?
| | Receptors, Estrogen | 1 | 2025 | 404 | 0.040 |
Why?
| | Dinoprostone | 1 | 2022 | 180 | 0.040 |
Why?
| | Glucosides | 1 | 2022 | 56 | 0.040 |
Why?
| | Interleukin-13 | 1 | 2022 | 146 | 0.040 |
Why?
| | Signal Transduction | 1 | 2015 | 5224 | 0.040 |
Why?
| | Acetylcysteine | 1 | 2022 | 139 | 0.040 |
Why?
| | Benzhydryl Compounds | 1 | 2022 | 81 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2022 | 269 | 0.040 |
Why?
| | Phospholipids | 1 | 2022 | 214 | 0.040 |
Why?
| | Estrogens | 1 | 2023 | 367 | 0.040 |
Why?
| | Adiponectin | 1 | 2022 | 242 | 0.040 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2022 | 231 | 0.040 |
Why?
| | Ligands | 1 | 2022 | 668 | 0.040 |
Why?
| | Lactobacillus | 1 | 2020 | 28 | 0.040 |
Why?
| | Cecum | 1 | 2020 | 37 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 561 | 0.040 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2023 | 411 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 112 | 0.040 |
Why?
| | Fatty Acids | 1 | 2022 | 457 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 143 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2022 | 784 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2025 | 1450 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2022 | 780 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4568 | 0.030 |
Why?
| | Hypertriglyceridemia | 1 | 2018 | 45 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1217 | 0.030 |
Why?
| | Milk | 1 | 2018 | 119 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2025 | 2514 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 474 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3551 | 0.030 |
Why?
| | Feces | 1 | 2020 | 496 | 0.030 |
Why?
| | Mitochondria | 1 | 2023 | 993 | 0.030 |
Why?
| | Male | 5 | 2022 | 73010 | 0.030 |
Why?
| | Weight Gain | 1 | 2018 | 561 | 0.030 |
Why?
| | Feeding Behavior | 1 | 2018 | 692 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 2110 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 766 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 768 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2933 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2023 | 6465 | 0.020 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 655 | 0.020 |
Why?
| | Macrophages | 1 | 2019 | 1507 | 0.020 |
Why?
| | Infant | 1 | 2023 | 10091 | 0.020 |
Why?
| | Pregnancy | 1 | 2018 | 7216 | 0.010 |
Why?
| | Aged | 1 | 2023 | 26217 | 0.010 |
Why?
|
|
Libby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|